Edwin P. M. Jansen - Concepedia

Author

Edwin P. M. Jansen

Also Known As

E JANSEN, E Jansen, E P Jansen, E P M Jansen, E. Jansen, E. P. M. Jansen, E.P.M. Jansen, Edwin Jansen, Edwin P M Jansen, Edwin P. Jansen

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

The Netherlands Cancer Institute Leiden University Medical Center Amsterdam UMC Location Vrije Universiteit Amsterdam Radboud University Nijmegen Karolinska Institutet

About

Edwin P. M. Jansen is an author at The Netherlands Cancer Institute specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	1.3K
2	Gastroenterology	7	7	934
3	Engineering	5	5	347
4	Health Sciences	3	3	288
5	Biostatistics	2	2	241

Edwin P. M. Jansen

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Gastric cancer Henk H. Hartgrink, Edwin P. M. Jansen, Nicole C.T. van Grieken, The Lancet	2009	880
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial Annemieke Cats, Edwin P. M. Jansen, Nicole C.T. van Grieken, The Lancet Oncology Surgical OncologyChemotherapy Versus ChemoradiotherapyGastrointestinal OncologyResectable Gastric CancerMedicine	2018	562
Variability in target volume delineation on CT scans of the breast Coen Hurkmans, Jacques Borger, Bradley R. Pieters, International Journal of Radiation OncologyBiologyPhysics Computed TomographyEngineeringMedical ImagingBiomedical ImagingTarget Volume Delineation	2001	208
Impact of the Extent of Surgery and Postoperative Chemoradiotherapy on Recurrence Patterns in Gastric Cancer Johan L. Dikken, Edwin P. M. Jansen, Annemieke Cats, Journal of Clinical Oncology	2010	203
Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS) Johan L. Dikken, Johanna W. van Sandick, HA Maurits Swellengrebel, BMC Cancer	2011	196
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer Astrid E. Slagter, Edwin P. M. Jansen, Hanneke W.M. van Laarhoven, BMC Cancer	2018	147
Does the combination of radiotherapy and debulking surgery favor survival in paranasal sinus carcinoma? Edwin P. M. Jansen, Ronald B. Keus, Frans J. M. Hilgers, International Journal of Radiation OncologyBiologyPhysics Adaptive RadiotherapyNeuro-oncologyParanasal Sinus CarcinomaRadiation TherapyMedicine	2000	123
Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancer Edwin P. M. Jansen, Mark Saunders, Henk Boot, International Journal of Radiation OncologyBiologyPhysics Surgical OncologyEsophageal CancerGastrointestinal OncologyMedicineGastroenterology	2006	93
A multicenter randomized phase III trial of neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy in resectable gastric cancer: First results from the CRITICS study. Marcel Verheij, Edwin P. M. Jansen, Annemieke Cats, Journal of Clinical Oncology Surgical OncologyGastrointestinal OncologyMedicineCancer ManagementPhase Iii Trial	2016	74
Interobserver Variation of Clinical Target Volume Delineation in Gastric Cancer Edwin P. M. Jansen, Jasper Nijkamp, Michael Gubanski, International Journal of Radiation OncologyBiologyPhysics Tumor BiologyEsophageal CancerGastrointestinal OncologyMedicineCancer Management	2009	66

Page 1